Ascend Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-85,000
Closed -$5.85M 228
2014
Q3
$5.85M Buy
+85,000
New +$5.85M 0.17% 138
2014
Q2
Sell
-48,202
Closed -$4M 235
2014
Q1
$4M Buy
48,202
+22,393
+87% +$1.86M 0.1% 155
2013
Q4
$1.67M Buy
25,809
+1,120
+5% +$72.5K 0.05% 167
2013
Q3
$1.57M Sell
24,689
-298
-1% -$18.9K 0.06% 182
2013
Q2
$1.05M Buy
+24,987
New +$1.05M 0.04% 160